Drug recall D-1453-2019
Product
MethylPREDNISolone Tablets, USP 8 mg, 25 tablets, Rx Only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India NDC 68382-917-11
Reason for recall
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Lots and codes
Lots: M713224, M713225, M713226, EXP Nov-19; M814746 EXP Sep-20; M816148 EXP Oct-20; M901600, M901601 EXP Feb-21
Recall details
- Recalling firm
- Zydus Pharmaceuticals USA Inc, Pennington, NJ
- Quantity
- 40872 25-count bottles
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- May 6, 2019
- Terminated
- September 16, 2021
Related products
- Methylprednisolone – drug information
- NDC 68382-917 Methylprednisolone · Methylprednisolone 8 mg/1 · Zydus Pharmaceuticals USA Inc.
- NDC 68382-918 Methylprednisolone · Methylprednisolone 16 mg/1 · Zydus Pharmaceuticals USA Inc.
- NDC 68382-916 Methylprednisolone · Methylprednisolone 4 mg/1 · Zydus Pharmaceuticals USA Inc.
- NDC 68382-919 Methylprednisolone · Methylprednisolone 32 mg/1 · Zydus Pharmaceuticals USA Inc.